# Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer

> **NCT00002836** · PHASE3 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 184 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** Filgrastim (G-CSF)
- **DRUG:** Carmustine
- **DRUG:** Cisplatin
- **DRUG:** Cyclophosphamide (CTX)
- **DRUG:** Etoposide
- **DRUG:** Thiotepa
- **PROCEDURE:** Peripheral Blood Stem Cell Transplantation

## Key facts

- **NCT ID:** NCT00002836
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-09-26
- **Primary completion:** 2006-03-09
- **Final completion:** 2006-03-09
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2018-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002836, "Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00002836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*